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This article aims to critically review developments in food allergy diagnostics with 
regard to the verification of specific IgE antibodies and the identification of the 
responsible allergens. Results of IgE-binding tests with food extracts are hampered 
by cross-reactive proteins, low-quality test agents, or both. Specificity can be 
increased by defining adequate cutoff values, whereas sensitivity can be improved by 
using high-quality test agents. IgE-binding tests with purified allergens enabled 
reliable quantification of allergen-specific IgE titers, with higher levels found in 
individuals with food allergy compared with individuals without food allergy. However, 
the overlap in individual test reactivity between allergic and nonallergic subjects 
complicates interpretation. Recombinant allergens and synthetic sequential epitopes 
enabled detection of sensitization profiles, with IgE specific to several allergens and 
substructures now being suggested as markers of severity, persistence, or both. 
However, high-power quantitative studies with larger numbers of patients are 
required to confirm these markers. IgE-binding tests merely indicate sensitization, 
whereas the final proof of clinical relevance still relies on family/case history, physical 
examinations, and provocation tests. Novel technologies promise superior 
diagnostics. Microarray technology permits simultaneous measurement of multiple 
IgE reactivities regarding specificity, abundance, reactivity, or interaction. Improved 
functional tests might enable reliable estimation of the clinical relevance of IgE 
sensitizations at justifiable expenses. 
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Epidemiologic studies based on food challenges indicate that 1% to 10.8% of the 
general population have immune-mediated nontoxic food hypersensitivity, which is 
the most common trigger of anaphylaxis in young age.[1] and [2] Food allergy includes 
IgE-mediated and non–IgE-mediated syndromes, where IgE-mediated manifestations 
are responsible for the majority of food-induced, immediate-type, immune-mediated 
hypersensitivity reactions.3 The development of an IgE-mediated response to food 
requires a series of molecular and cellular interactions, which involve antigen-
presenting cells, T lymphocytes, and B lymphocytes.[4] and [5] 
Depending on the route of sensitization, food allergy is the result of either genuine 
reactivity to comestibles through the gastrointestinal tract (class I food allergens) or 
secondary sensitization to cross-reactive food allergens as a consequence of the 
initial reactivity to homologous pollen-related allergens (class II food allergens).[6] and 
[7] The majority of class I food allergens are heat stable and resistant to degradation 
or proteolytic digestion, whereas class II food allergens are usually easily 
degradable.8 Stable class I food allergens have the potential to induce severe 
reactions, whereas easily degradable class II food allergens tend to induce milder 
reactions often limited to oral allergy symptoms.[6], [8] and [9] Another characteristic of 
food allergens is the occurrence of sequential (linear), as well as conformational 
(discontinuous), IgE epitopes. Sequential epitopes have been suggested to be more 
important in class I food allergy, whereas conformational epitopes have been 
suggested to be more relevant in class II food allergy.10 
Accurate diagnosis of food allergy and appropriate treatment options depend on the 
verification of functionally relevant, allergen-specific IgE antibodies (sIgEs), as well as 
on the identification of the responsible allergenic molecule or molecules. Today, a 
variety of in vivo and in vitro test systems are available to investigate sIgEs as 
biomarkers for allergy specification.11 However, a positive sIgE test result merely 
identifies sensitization to a particular allergen and does not permit definitive 
differentiation between clinically relevant IgE reactivity (ie, reactivity that is capable to 
cross-link FcεRI receptors) and IgE reactivity not accompanied by clinical symptoms 
(ie, reactivity without an effector cell response).[11], [12] and [13] As a consequence, the 
clinical interpretation of sIgE test results with food extracts is often impeded by 
clinically irrelevant food-food or pollen-food cross-reactive IgE antibodies, leading to 
positive test results in subjects without clinical food allergy.[14] and [15] A further problem 
is that commercially available food extracts are often not standardized, and the 
content of functional allergenic molecules varies based on the nature and quality of 
the food, the extraction procedure, and storage conditions.[16], [17], [18], [19] and [20] 
Double-blind, placebo-controlled food challenges overcome the problem of 
determining the clinical relevance of sIgE reactivity, which is why they are still the 
gold standard in food allergy diagnostics, against which all other approaches should 
be verified.[11], [13] and [21] However, in vivo provocation tests with food allergens carry 
the risk of inducing severe allergic reactions.[11] and [22] Therefore functional sIgE tests 
to detect basophil activation in vitro by using either patients' cells directly or serum 
IgE coated to a basophil cell line have been suggested as surrogates.[23] and [24] 
Progress in biochemistry and molecular biology allowed for the identification, cloning, 
and recombinant production of allergenic proteins, as well as the synthesis of IgE 
epitope–emulating peptides of a number of food allergens.[10], [16] and [25] These new 
measures enabled component-resolved diagnostics of food allergy by detecting and 
quantifying IgE antibodies specific to a protein or even a sequential epitope. 
Component-resolved diagnosis revealed individual sensitization patterns to (1) 
different proteins of an allergenic food, (2) homologous proteins in different foods, 
and (3) different epitopes of a single allergenic molecule.[26], [27], [28], [29], [30] and [31] 
Nevertheless, cumulative analyses of these results also revealed the presence of 
common sensitization patterns to major allergenic molecules of a single food, as well 
as to immunodominant IgE epitopes in a single allergenic molecule.[26], [27], [32] and [33] 
These findings encourage the use of panels of purified native or recombinant 
allergenic molecules and the use of synthetic sequential epitopes for an elaborate 
molecular analysis of sensitization patterns. This promises refined diagnosis, risk 
assessment, and prediction in food allergy. The present review aims at providing a 
general conspectus on the basis and current effect of diagnostic IgE-binding tests 
with recombinant food allergens or the respective sequential epitopes. 
Immunoblot analyses allow for the identification of target molecules 
Immunoblot analysis of sIgE reactivity to food extracts with labeled anti-human IgE 
antibodies after gel electrophoresis and Western blotting of the allergenic protein 
source first enabled (1) the identification and discrimination of allergenic molecules 
from a single source and (2) the detection of individual sensitization patterns to 
specific allergenic molecules in different but cross-reactive sources.34 In many cases 
overall sensitization to immunodominant proteins, as well as individual sensitization 
to minor allergenic proteins, was observed.[35], [36], [37], [38] and [39] Nevertheless, the 
pattern of sIgE reactivity can be highly disparate among patients with allergy to the 
same food.[39] and [40] 
Immunodominant proteins with identical or highly similar molecular masses were 
detected in extracts of different sources, indicating food-pollen41 or food-food cross-
reactivity.[35], [36], [42] and [43] Preabsorption of patient serum with purified native or 
recombinant allergenic molecules before immunoblot experiments confirmed the 
expression of cross-reactive sIgEs, which are capable of binding proteins from 
different sources with conserved binding sides and sufficient sequential, as well as 
structural, homology.44 Accordingly, immunoblot inhibition studies demonstrated 
attenuation of sIgE reactivity to immunodominant proteins of crude allergen extracts, 
as well as to purified allergens, by means of preabsorption of the sera with purified 
proteins from a homologous source.[36], [37], [45], [46] and [47] Reciprocal IgE antibody 
neutralization experiments verified the concept of pollinosis as a trigger of food 
allergy in terms of secondary cross-reactivity of pollen-specific IgEs to class II food 
allergens.48 Accordingly, recombinant Bet v 1, the major birch pollen allergen, was 
shown to act as a potent inhibitor of IgE cross-reactivity to the homologous proteins 
from apple, carrot, celery, hazelnut, and peach,[45] and [47] whereas homologous Api g 
1, Mal d 1, and Dau c 1 from celery, apple, and carrot were inefficient in inhibiting IgE 
reactivity to Bet v 1.45 This can be explained by the “polyclonal” situation of the 
immune response, in which a number of different IgE antibodies recognize the 
primary antigen but only a few of them react with the secondary antigen. 
Immunoblot analyses are also useful in evaluating the allergen-specific influence on 
the course of food allergy (eg, regarding the effect of individual sIgE sensitization 
patterns to different allergenic molecules of a single source). As an example, 
immunoblot analyses elucidated why allergy to certain plant foods manifests with 
relatively mild clinical conditions in patients with birch pollen allergy from central 
Europe,[6], [9] and [14] whereas the same comestibles have the capacity to provoke 
severe systemic reactions in patients without (birch) pollen allergy from the 
Mediterranean area.[6] and [49] It could be demonstrated that Bet v 1–homologous class 
II food allergens are responsible for immunodominant sIgE reactivity in patients with 
birch pollen allergy, whereas sera of patients without (birch) pollen allergy frequently 
react to class I food allergenic lipid transfer proteins of these comestibles.[28], [50], [51] 
and [52] 
Taken together, immunoblot experiments are an essential basis for the development 
of in vivo, as well as in vitro, sIgE test systems with purified allergens. However, an 
immunoblot detection of sIgEs is not a proof of clinical relevance because a single 
IgE epitope is sufficient for the in vitro reactivity. 
Skin tests with purified allergenic molecules 
The easiest approach in establishing whether a patient possesses sIgEs is a skin 
prick test (SPT) with commercially prepared allergen extracts.53 The diagnostic 
potential of skin tests depends first of all on the quality of the test agents. 
Unfortunately, quality and composition of the available, mostly nonstandardized food 
extracts is highly variable. One might speculate that this is especially true for labile 
plant food allergens. However, skin tests with fresh extracts or prick-by-prick 
approaches with fresh food frequently revealed higher assay sensitivity in 
comparison with tests with commercial extracts for all classes of food allergens.[54], 
[55], [56] and [57] Nevertheless, skin tests with commercial food extracts of class I food 
allergens are usually characterized by high sensitivity and negative predictive values 
of more than 90%, whereas their specificity is generally poor, and a positive test has, 
on average, a 50% positive predictive value.58 In contrast, skin tests with commercial 
food extracts of class II food allergens can also be vitiated by low sensitivity (eg, 
because of the low proteolytic stability of the allergenic components).[28], [59], [60] and [61] 
Just as with in vitro sIgE tests (see below), diagnostic skin tests are further hampered 
by the fact that positive test results are frequently seen in a considerable proportion 
of individuals without adverse reactions to the respective food.[54], [62], [63], [64], [65] and [66] 
The significance of a positive test result with a food extract is mainly deteriorated by 
the presence of multiple molecules, each with the potential to cross-react with IgEs 
specific to homologous proteins of different biologic sources.[14], [17] and [67] As a 
consequence, positive testing with a food extract frequently just reflects an initial 
sensitization to, for example, a homologous pollen allergen, where cross-reactivity is 
often not (yet) correlated with the development of clinical food allergy.14 Thus, a 
negative skin test result is very likely to confirm the absence of IgE-mediated food 
hypersensitivity, whereas positive test results merely indicate sensitization. 
Nevertheless, studies aimed at evaluating the diagnostic capacity of SPTs were 
capable of defining wheal size diameters that represent predictive decision points for 
clinical food allergy. However, the accuracy of SPT decision points depends on the 
quality of the test agent.[33], [68], [69], [70] and [71] Purified native or recombinant allergenic 
molecules represent standardized test agents of precisely defined quality and 
promise crucial diagnostic progress. Moreover, recombinant allergenic molecules 
enable component-resolved identification of individual sensitization patterns and thus 
discrimination of different patient groups with respect to, for example, severity scores. 
However, only a few comparative SPT studies with purified food allergens have been 
conducted,[28], [72], [73] and [74] which is mainly due to the high demands of approval in 
clinical trials as requested by the institutional review boards and regulatory authorities 
to ensure patient safety (test allergens have to be licensed as biotechnologic 
products). These few studies verified a superior diagnostic potential of recombinant 
allergens. However, the sensitivity of a skin test with a single molecule is often lower 
compared with that of a test with an allergen extract that contains several different 
allergenic molecules. Hence, skin tests with recombinant molecules need to include 
panels of recombinant allergens covering all immunodominant structures present in a 
given food.[72] and [74] 
Quantification of IgE antibodies 
Today, sIgEs can be measured within the clinical routine by using commercially 
available assays (eg, RASTs and EASTs, respectively), ELISAs, and highly reliable 
quantitative and automated methods using the fluorescence enzyme immunoassay 
or the reverse sandwich immunoassay with direct chemiluminescent technology.[75] 
and [76] These in vitro assays are especially useful when SPTs cannot be performed or 
interpreted in patients with generalized dermatitis or in those who must continue to 
take antihistaminic medications.77 A further advantage of in vitro sIgE determinations 
is the elimination of the risk for systemic reactions existing in all provocation tests.78 
Quantitative in vitro assays also offer advantages over the at-best-semiquantitative 
immunoblot analyses. The former enable investigation of allergens in their native 
form, whereas the denaturing conditions of the latter (SDS gel electrophoresis) 
include a stronger risk of not presenting native IgE-binding epitopes, possibly causing 
detection failures.[79] and [80] 
RAST assays with crude allergen extracts allowed, for the first time, estimation of 
sIgE serum concentrations,[81], [82] and [83] but the accuracy of in vitro sIgE 
determinations is highly variable.[54], [84] and [85] This is, for example, due to lacking 
standardization of the test agents, as well as to instability of some of the respective 
allergenic proteins.[16], [17], [18], [19] and [20] Moreover, some clinically relevant food 
allergens with high structural stability and resistance to the gastrointestinal 
environment demonstrate only low RAST signals because of their low abundance in 
the extracts.86 In general, the universal problem in food allergy testing (ie, relatively 
high sensitivity with overall low specificity) also applies for quantitative sIgE 
determinations (see skin testing section). 
IgEs specific to allergenic proteins are the causative agents in the clinical 
manifestation of food allergy. Therefore, one would expect a direct correlation 
between their titers and the probability/severity of the allergic symptoms. Indeed, on 
average, higher sIgE levels were found in subjects with food allergy compared with 
those in subjects without food allergy. Nevertheless, depending on the food 
investigated, a huge overlap in individual sIgE reactivity between healthy subjects 
and subjects with food allergy also became evident.[35], [87], [88], [89] and [90] Several 
reasons might be suggested to explain the overlap in test reactivity. First, low sIgE 
signals in allergic patients might be attributed to sensitization to a low-abundance, 
highly resistant protein with particular allergenic potency. Second, allergen-specific 
IgGs with the capacity to compete for the IgE-binding epitopes might cause invalid 
effector cell activation, despite the presence of adequate sIgEs[91], [92] and [93]; a few 
studies even hint at a high IgE/IgG ratio as a prognostic marker in food allergy,[94] and 
[95] whereas others did not verify such a correlation.96 Because IgE versus IgG 
competition might also interfere with IgE quantifications, novel approaches initially 
capture all serum IgE at a solid phase and use labeled allergen for the detection of 
the captured antibodies.97 Third, qualitative differences of the respective sIgEs might 
be responsible for uneven efficacy in effector cell activating.98 Finally, monoclonality 
is sufficient for in vitro reactivity, whereas polyclonality is required for effector cell 
activation (see the introduction to this article). 
In accordance with similar SPT attempts (see above), efforts were made to estimate 
cutoff values (decision points) of sIgE titers that enable prediction of food challenge 
outcome.[58], [99] and [100] In general, these studies verified that increasing sIgE titers 
correlate with an increasing risk of reactivity on challenge and that reasonable 
threshold values can be defined to avoid challenges in a subgroup of patients.[58], [71], 
[89], [101], [102], [103], [104] and [105] However, diagnosis of food allergy based on decision 
points is hampered by a huge overlap in test reactivity between healthy subjects and 
patients with food allergy. The definition of more stringent cutoff values has the 
potential to improve the specificity, as well as the positive predictive value. However, 
this will inherently also result in a significant decrease of sensitivity, as well as in a 
reduced negative predictive value, by increasing the number of false-negative results. 
Moreover, the predictive power of sIgE determinations significantly varies among 
different food allergens.[71], [104] and [105] There the cutoff values for the same food 
allergen significantly varied between different studies, where age, demographic, 
ethnic, and symptomatic dependencies became evident.[31], [70], [106] and [107] Hence 
decision points for sIgE determinations need to be carefully established (1) for each 
food, (2) for several age groups, and (3) even separately for each health care center. 
Specificity of IgE determinations is predominantly affected by homologous cross-
reacting proteins, whereas sensitivity mainly depends on the quality of the test agent 
or other assay limitations. Therefore the use of standardized high-quality allergens 
has the potential to significantly improve sensitivity and to increase the negative 
predictive value by decreasing the number of false-negative results (for problems and 
benefits of sIgE testing with different allergen preparations, see Table I). Accordingly, 
studies with recombinant allergens revealed substantially improved sensitivity.[16], [31], 
[61], [88], [108] and [109] It is noteworthy that the use of a mix of recombinant major cherry 
allergens resulted in 95% sensitivity compared with 65% for cherry extract.31 
Supplementation of natural extracts with recombinant allergens is a further promising 
approach to ensure diagnostic sensitivity and improve quantitative performance.110 
Moreover, component-resolved sIgE determinations with recombinant allergens also 
promise refined diagnosis. This might be exemplified by the observation that high 
sIgE titers to recombinant lipid transfer protein in combination with low or absent 
reactivity to Bet v 1 homologues are clearly correlated with systemic reactions in 
apple, peach, cherry, and hazelnut allergy, whereas the opposite is true for patients 
with oral allergy syndrome at consumption of these foods.[31], [33], [111] and [112] 
Table I.  
Benefits and problems of allergen preparations used for in vitro diagnostics 
 Natural extracts Native allergens Recombinant proteins 
Benefits 
Easy to prepare 
Ideally, all allergenic proteins 
are present 
Enabling of 
component-resolved 
diagnosis 
Native protein 
structures are mostly 
preserved 
Presence of all 
natural isoforms and 
posttranslational 
modifications 
Enabling of 
component-resolved 
diagnosis and 
application of a 
single isoform 
Lack of impurities 
with other food 
proteins 
Standardization of 
amount and 
structural 
characteristics 
Problems Standardization problems caused by the natural 
Laborious preparation Laborious 
 Natural extracts Native allergens Recombinant proteins 
variability of active 
ingredients (eg, various 
isoforms with different IgE-
binding capacities) and 
endogenous degradation that 
also can cause low assay 
sensitivity 
Complex mixtures of 
allergenic and nonallergenic 
components sometimes 
resulting in low assay 
specificity 
Yield depends on 
composition of source 
material 
Risk of variable batch 
composition caused 
by different 
copurification yields of 
isoforms 
Risk of low-level 
contamination with 
other allergens from 
the same source and 
purification artifacts 
preparation 
Proteins can be 
unfolded or partially 
unfolded and might 
not be properly 
modified after 
translation 
Risk of low-level 
contamination with 
components of the 
expression system 
and purification 
artifacts 
Full-size table 
 
Children mostly outgrow class I food allergies.113 Early RAST studies suggested a 
correlation of sIgE titers and the pace of tolerance development.114 Further studies 
with crude allergen extracts mostly verified a general trend of a correlation between 
high sIgE titers and slow outgrowth of cow's milk or hen's egg allergy.[115], [116], [117], [118] 
and [119] Yet again a significant overlap in serum sIgE reactivity of patients with early 
and late outgrowth was apparent. However, systematic studies with recombinant food 
allergens as sensitivity-improved test agents in quantitative sIgE determinations are 
still lacking. Consequently, the final concept in the diagnosis of food allergy by 
differentiating quantitative approaches has yet to be defined. Extensive surveys are 
required using the full set of available recombinant allergens to (1) determine 
authentic panels of recombinant allergens with respect to best sensitivity 
performance, (2) define the most reliable cutoff values, and (3) develop reasonable 
strategies in risk assessment and prediction of permanence. 
Diagnosis of food allergy with synthetic sequential epitopes 
Today, the stability of class I food allergens is generally believed to be responsible for 
their capacity to provoke severe systemic reactions.8 They have the potential to 
retain IgE reactivity even after digestion, probably because of sequential IgE 
epitopes, whereas in class II food allergens a single point mutation can result in an 
almost complete loss of IgE reactivity based on the disruption of the tertiary 
structure.[10], [120], [121], [122] and [123] Studies on conformational IgE epitopes are rare 
because the investigation of discontinuous epitopes is far more challenging than the 
investigation of sequential epitopes. The latter are detectable by means of epitope 
mapping with captured overlapping synthetic peptides that represent the entire amino 
acid sequence of the respective allergen.25 However, this technology has critical 
limitations. Most importantly, it allows a maximum peptide length of 15 amino acids 
because of less than 100% efficiency of the coupling reaction.10 Using 10 to 15 mers 
at shifting offsets of 1 to 7 amino acids, several patient-specific, as well as 
immunodominant, epitopes were identified in different class I food allergens.[26], [27], 
[29], [32], [124], [125], [126], [127], [128], [129] and [130] However, other studies at different shifting 
offsets, with different peptides sizes, or both revealed different sets of 
immunodominant sequential epitopes for the same allergens.[29], [124], [125], [126], [127], [130] 
and [131] 
Nevertheless, approaches to use these alleged immunodominant peptides for the risk 
assessment of life-threatening symptoms, as well as the prediction of persistence in 
food hypersensitivity, were apparently successful. In wheat-dependent exercise-
induced anaphylaxis, all sera from affected patients showed significant sIgE reactivity 
to the respective peptides, whereas none of the sera from nonatopic control subjects 
demonstrated reactivity, and sera from control patients with atopic dermatitis showed 
very low to nonexistent reactivity.[29] and [130] The sera of individuals with a history of 
more severe peanut-induced allergic reactions recognized a higher number of 
sequential Ara h 1, Ara h 2, and Ara h 3 epitopes than sera from individuals with 
milder symptoms. However, a higher number of recognized epitopes was also 
correlated with larger sIgE polyclonality.[132] and [133] Furthermore, it could be 
demonstrated that sera of patients with persistent food allergy recognized specific 
sequential epitopes and showed significantly higher peptide-specific IgE titers than 
sera of patients who subsequently gained tolerance.[125] and [134] Individual patterns in 
sequential epitope binding were variable, and a significant overlap in individual test 
reactivity between severely affected subjects and patients with milder symptoms was 
also evident. 
In conclusion, risk assessment and prediction of permanence appears to be 
attainable in class I food allergy by using sequential epitope-emulating peptides. 
However, the detection of different immunodominant sequential epitopes in the same 
allergenic protein, depending on the design of the study, demands definite 
explanation. Additional high-power studies with quantitative approaches in a larger 
number of patients are requested to confirm the advantages of sequential peptides 
with respect to differentiating diagnostics in food allergy. 
Future perspectives 
The use of recombinant food allergens or synthetic sequential epitopes in 
experimental, as well as commercial, test systems allows, for the fist time, highly 
sensitive detection of sensitization profiles. IgEs specific to several target allergens, 
substructures, or both have been suggested as markers of severity, persistence, or 
both; progress in molecular allergology promises identification of several other 
targets. Nevertheless, well-designed high-power studies will be required to 
substantiate current and future findings. 
Repeated exposure to cross-reactive antigens increases sIgE polyclonality, as well 
as the affinity maturation of these antibodies.135 In cross-sensitized patients this 
process represents an imminent danger regarding a possible switch from a currently 
existing pollinosis to a future food-pollen allergy syndrome or from a current single 
food allergy to multiple food hypersensitivity.[136] and [137] Regarding a currently not yet 
clinically relevant cross-reactivity, component-resolved analyses with recombinant 
allergens promise improved prediction by means of (1) exact quantification of 
different sIgE titers and (2) quantitative reciprocal cross-inhibition experiments 
performing sequential preabsorption of the sera with increasing amounts of 
homologous allergens.48 Such measurements allow for an estimation of cross-
reactive sIgE fractions, as well as the determination of their relative affinities to 
different homologous cross-reacting proteins. In turn, this enables differentiation 
between sensitizations with and without the potential for future clinical significance. 
Consequently, studies with recombinant allergens using modern automated 
approaches for high-throughput detection of sIgE reactivity might give rise to 
improved diagnostics. 
Microarray technology enables sIgE testing in a multiplex format and allows for the 
simultaneous measurement of many IgE clones with different specificities in complex 
arrays comprising large numbers of recombinant allergens, peptide epitopes, or 
both.[132], [138] and [139] A major advantage lies in the potential to investigate large 
numbers of analytes in parallel while only using minute amounts of sera and 
antigens. Therefore, component-resolved analysis with this technology can facilitate 
simultaneous detection of sIgE abundance, functionality, and interaction concerning 
numerous allergenic determinants. However, this untargeted “random testing” 
generates a high amount of not necessarily correlating data. Clinical interpretation 
would currently rely on available information from testing these reagents by using 
low-throughout methods with modern bioinformatics approaches to identify novel 
diagnostic coherences. However, a number of adequately powered clinical trials are 
required before the introduction of this technology into ordinary clinical practice. 
Improved human basophil activation tests use flow cytometric readouts of, for 
example, CD63 or CD203c for the assessment of activation.[23] and [24] However, the 
diagnostic potential of basophil tests with allergen extracts appears not to be superior 
to sIgE determinations because a broad variability in basophil activity exists between 
different donors and different allergens.24 Moreover, an overlap in individual test 
reactivity between allergic and nonallergic subjects again complicates 
interpretation.140 Using recombinant allergens, sequential epitopes, or both might 
improve the diagnostic reliability, whereas restrictions arising from approval 
regulations for studies on provocation tests with recombinant allergens are irrelevant. 
Coupling of the diversity of microarray technology with the assessment of biologic 
activity in cell-based assays might be used for the parallel detection of several 
activation markers, enabling reliable estimation of the clinical relevance of sIgE 
sensitizations at justifiable expenses.141 
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